Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study.

Elizabeth G Araujo; Matthias Englbrecht; Sabrina Hoepken; Stephanie Finzel; Eleni Kampylafka; Arnd Kleyer; Sarah Bayat; Verena Schoenau; Axel Hueber; Juergen Rech; Georg Schett

doi:10.1016/j.semarthrit.2018.05.011

Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study.

Elizabeth G Araujo, Matthias Englbrecht, Sabrina Hoepken, Stephanie Finzel, Eleni Kampylafka, Arnd Kleyer, Sarah Bayat, Verena Schoenau, Axel Hueber, Juergen Rech, Georg Schett

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Original Article › peer-review

101 Citations (Web of Science)

Original language	English
Pages (from-to)	632-637
Journal	SEMINARS IN ARTHRITIS AND RHEUMATISM
Volume	48
Issue number	4
DOIs	https://doi.org/10.1016/j.semarthrit.2018.05.011
Publication status	Published - 2019

Keywords

ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY
DOUBLE-BLIND
CONTROLLED-TRIAL
EFFICACY
SAFETY
PHASE-3
SECUKINUMAB
ETANERCEPT
ADALIMUMAB
DISEASE

Access to Document

10.1016/j.semarthrit.2018.05.011

Cite this

Araujo, E. G., Englbrecht, M., Hoepken, S., Finzel, S., Kampylafka, E., Kleyer, A., Bayat, S., Schoenau, V., Hueber, A., Rech, J., & Schett, G. (2019). Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study. SEMINARS IN ARTHRITIS AND RHEUMATISM, 48(4), 632-637. https://doi.org/10.1016/j.semarthrit.2018.05.011

@article{d8d4eb8cc33b40109aca06c9fc57228b,

title = "Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study.",

keywords = "ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY, DOUBLE-BLIND, CONTROLLED-TRIAL, EFFICACY, SAFETY, PHASE-3, SECUKINUMAB, ETANERCEPT, ADALIMUMAB, DISEASE",

author = "Araujo, {Elizabeth G} and Matthias Englbrecht and Sabrina Hoepken and Stephanie Finzel and Eleni Kampylafka and Arnd Kleyer and Sarah Bayat and Verena Schoenau and Axel Hueber and Juergen Rech and Georg Schett",

year = "2019",

doi = "10.1016/j.semarthrit.2018.05.011",

language = "English",

volume = "48",

pages = "632--637",

journal = "SEMINARS IN ARTHRITIS AND RHEUMATISM",

issn = "0049-0172",

number = "4",

}

Araujo, EG, Englbrecht, M, Hoepken, S, Finzel, S, Kampylafka, E, Kleyer, A, Bayat, S, Schoenau, V, Hueber, A, Rech, J & Schett, G 2019, 'Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study.', SEMINARS IN ARTHRITIS AND RHEUMATISM, vol. 48, no. 4, pp. 632-637. https://doi.org/10.1016/j.semarthrit.2018.05.011

Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study. / Araujo, Elizabeth G; Englbrecht, Matthias; Hoepken, Sabrina et al.
In: SEMINARS IN ARTHRITIS AND RHEUMATISM, Vol. 48, No. 4, 2019, p. 632-637.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study.

AU - Araujo, Elizabeth G

AU - Englbrecht, Matthias

AU - Hoepken, Sabrina

AU - Finzel, Stephanie

AU - Kampylafka, Eleni

AU - Kleyer, Arnd

AU - Bayat, Sarah

AU - Schoenau, Verena

AU - Hueber, Axel

AU - Rech, Juergen

AU - Schett, Georg

PY - 2019

Y1 - 2019

KW - ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY

KW - DOUBLE-BLIND

KW - CONTROLLED-TRIAL

KW - EFFICACY

KW - SAFETY

KW - PHASE-3

KW - SECUKINUMAB

KW - ETANERCEPT

KW - ADALIMUMAB

KW - DISEASE

U2 - 10.1016/j.semarthrit.2018.05.011

DO - 10.1016/j.semarthrit.2018.05.011

M3 - Original Article

C2 - 30037432

SN - 0049-0172

VL - 48

SP - 632

EP - 637

JO - SEMINARS IN ARTHRITIS AND RHEUMATISM

JF - SEMINARS IN ARTHRITIS AND RHEUMATISM

IS - 4

ER -